Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib in Ankylosing Spondylitis Non-Responders to NSAIDs
NCT01091675Phase 3Completed
- Sponsor
- Fundación Española de Reumatología
- Start
- Sep 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etoricoxib in ankylosing spondylitis (AS), sponsored by Fundación Española de Reumatología. Started Sep 2010; status: completed.
02
Drugs
etoricoxib
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT01091675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091675.